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Nordihydroguaiaretic acid (NDGA) is a phenolic antioxidant found in the leaves and twigs of the evergreen desert shrub, Larrea
tridentata (Sesse and Moc. ex DC) Coville (creosote bush). It has a long history of traditional medicinal use by the Native
Americans and Mexicans. The modulatory eﬀects of topically applied NDGA was studied on acute inﬂammatory and oxidative
stress responses in mouse skin induced by stage I tumor promoting agent, 12-O-tetradecanoylphorbol-13-acetate (TPA). Double
TPA treatment adversely altered many of the markerresponses of stageI skintumorpromotioncascade.Pretreatment of NDGA in
TPA-treated mice mitigated cutaneous lipid peroxidation and inhibited production of hydrogen peroxide. NDGA treatment also
restored reduced glutathione level and activities of antioxidant enzymes. Elevated activities of myeloperoxidase, xanthine oxidase
and skin edema formation in TPA-treated mice were also lowered by NDGA indicating a restrained inﬂammatory response.
Furthermore, results of histological study demonstrated inhibitory eﬀect of NDGA on cellular inﬂammatory responses. This
study provides a direct evidence of antioxidative and anti-inﬂammatory properties of NDGA against TPA-induced cutaneous
inﬂammationand oxidative stress corroborating its chemopreventive potential against skin cancer.
1.Introduction
Nordihydroguaiaretic acid (NDGA), 2,3-dimethyl-l,4-bis (3,
4-dihydroxyphenyl) butane (Figure 1(a))i sap l a n tl i g n a n
derived from the leaves and twigs of shrub creosote bush,
Larrea tridentata (Sesse and Moc. ex DC) Coville; family
Zygophyllaceae. Creosote bush dominates areas of the desert
southwest in the USA and Northern Mexico, as well as some
areas of Argentina [1]. It is also known as chaparral and
greasewood in the USA and gobernadora (governess) and
hediondilla (little smelly one) in Mexico. This shrub has a
long history of traditional medicinal use for a variety of
health problems by the Native Americans and Mexicans
[1]. Chaparral tea has been used in the folk medicine for
the treatment of more than 50 ailments including infertil-
ity, tuberculosis, arthritis, diabetes, kidney and gallbladder
stones, pain and inﬂammation [1]. The concentration of
NDGA in L. tridentata leaves is in the range of 5%–10%
of dry weight [1]. NDGA is a recognized inhibitor of
lipoxygenase (LOX) and has antioxidant and free radical
scavenging properties [2, 3]. Protective eﬀect of NDGA has
been observed against hepatic and renal toxicities induced
by ferric-nitrilotriacetate (Fe-NTA) [4]. It also showed pro-
tective eﬀect against ozone-induced tyrosine nitration in
lungs [2], potassium dichromate-induced oxidative stress
and nephrotoxicity [3] and streptozotocin-induced diabetic
nephropathy [5]. Besides its antioxidant activity, NDGA
has several other properties, which are of potential use for2 Evidence-Based Complementary and Alternative Medicine
humans such as itacts as an enzyme inhibitor [6],antimicro-
bial agent [7, 8], potential vaso- and brancho-dilating agent
[9] and antimutagenic agent [10].
In contrast with the beneﬁcial eﬀects described above
for NDGA, adverse eﬀects for chaparral containing products
have also been observed when ingested in high doses [1, 11].
Therefore, NDGA was removed from the generally regarded
as safe (GRAS) list of the Food and Drug Administration
(FDA) in 1968 following several reports of nephrotoxicity
and hepatotoxicity in humans [12, 13].
NDGA has shown chemopreventive activity in various
models of carcinogenesis [4, 14]. It restores expression of
silenced E-cadherin gene in human breast cancer cell lines
and in xenografts [15] and reduces the lung adenoma mul-
tiplicity in urethane-treated mice [14]. NDGA suppresses
benzoyl peroxide (BPO) and 12-O-tetradecanoylphorbol-
13-acetate (TPA)-induced ornithine decarboxylase (ODC)
activity and tumor promotion in murine skin [16–18]. Since
metabolic products of LOX pathway play an important
role in tumor promotion, anti-LOX activity of NDGA has
been identiﬁed as one of the possible mechanisms of its
chemopreventive eﬀect [17].
Skin cancer is a major health problem associated with
mortality and morbidity. Chemoprevention is one of the
many favorite current approaches applied to ameliorate the
occurrence of skin cancer [19]. A number of chemopreven-
tiveagentshavebeentestedfortheireﬃcacyinmitigating the
responses of promotion stage of skin cancer development,
as this stage is observed to be susceptible to reversibility
[20]. TPA is the most widely used tumor-promoting agent
in experimental skin carcinogenesis studies. TPA treatment
results in oxidative stress and a decrease in skin antioxidants
[21]. Recent studies have suggested that the double TPA
application model is appropriate to predict the inhibitory
potential of a test compound against tumor promotion in
skin [22, 23].
Certain natural products, fruits, vegetables, common
beverages and several herbs are rich sources of pharmaco-
logically active chemicals with diversiﬁed activities [22–25].
Due to low toxicity and relative safety natural compounds
have promising chemopreventive potential with capacity to
intervenemore than onecritical pathway[26, 27].Therefore,
in the present study we tested the eﬀect of NDGA against
inﬂammatory and oxidative stress responses induced by
double TPA application in mouse skin. These inﬂammatory
and oxidative stress responses empirically represent typical
stage I tumor promotion events.
2.Methods
2.1. Animals. Swiss albino female mice (25±2g)werepro-
vided by the Central Animal House Facility of the University
and maintained under standard laboratory conditions (tem-
perature 25±2◦C; photoperiod of 12h) on a commercial
p e l l e td i e ta n dw a t e rad libitum. The study protocols were
approved by the Institutional Animals Ethics Committee
(project #266).
2.2. TPA Application Protocol and Skin Tissue Processing.
Dorsal skin of animals was shaved using surgical clippers
(Oster Professional Products, McMinnville, TN, USA) two
days before commencement of treatment. NDGA (Sigma-
Aldrich Co., St Loius, MO, USA; 15 and 25μmol in 100μl
of acetone, BDH, Mumbai, India) was topically applied
onto the shaved area of dorsal skin 1h before application
of TPA (Sigma; 10nmol in 100μlo fa c e t o n e ) .T h es a m e
doses of NDGA and TPA or acetone were applied at an
interval of 24h. The timing (24h apart) of double TPA
application produced the same level of oxidative stress as
produced in twice-weekly application protocol (24h–72h)
used in skin tumor promotion studies [23]. A schematic
representation of dosing schedule is given in Figure 1(b).
Animals were sacriﬁced by cervical dislocation under mild
anesthesia 1h after the second TPA application and tissue
from the dorsal area was surgically removed. A piece of
skin was preserved in 10% neutral buﬀer formalin for
histological investigation. Homogenates were prepared in
chilled phosphate buﬀer (0.1 M, pH 7.4) using Poly-
tron homogenizer (Kinematica, Inc., Bohemia, NY, USA).
The homogenized tissue was centrifuged at 10500g for
30min at 4◦C to obtain the post-mitochondrial supernatant
(PMS).
2.3. Myeloperoxidase Activity and Edema Formation. The
Myeloperoxidase (MPO) activity was determined by the
method of Bradley et al. [28] and expressed as units/min/mg
protein. One unit of MPO activity was deﬁned as that
degrades 1μmol of peroxide per min. The edema formation
in skin of various groups of animals was measured using
the skin punch method of Huang et al. [29]a n dr e s u l ti s
expressed as mg/punch.
2.4. Lipid Peroxidation, Hydrogen Peroxide Production and
Xanthine Oxidase Activity. Lipid Peroxidation (LPO) was
measured using the procedure of Uchiyama and Mihara
[30]a n dt h er a t eo fL P Ow a sd e t e r m i n e da sn m o lo ft h i o -
barbituric acid reactive substances (TBARS) formed/h/g of
tissue. Hydrogen peroxide (H2O2) production was measured
by the method of Pick and Keisari [31]a n dc a l c u l a t e d
asnmol H2O2/h/g tissue. The xanthine oxidase (XO) activity
was measured by the method of Stripe and Della-Corte
[32] and results are expressed asμg uric acid formed/mg
protein.
2.5. Skin Antioxidants. Glutathione (GSH) was measured by
the method of Jollow et al. [33] and result is expressed as
nmol GSH/g tissue. Activities of glutathione peroxidase
(GPx) were measured by Lawrence and Burk [34]a n d
glutathione reductase (GR) was measured according to
the method of Carlberg and Mannervik [35]a n dc a l c u -
lated asnmol nicotinamide adenine dinucleotide phosphate
(NADPH, Sigma) oxidized/min/mg protein. Glutathione S-
transferase (GST) activity was measured by the method of
Habig et al. [36] and expressed asnmol 1-chloro-2,4-dini-
trobenzene (CDNB,Sigma) conjugatesformed/min/mg pro-
tein. Catalase (CAT) activity was assayed by the method ofEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: (a) Chemical structure of NDGA and (b) schematic
representation of dosing schedule in diﬀerent groups of animals.
Animals were divided into six groups I–VI (n=6). Control animals
(Group I) were treated with topical application of acetone (Ac,
100μl). Group II animals were treated with 10nmol of TPA/100μl
of acetone. NDGA (15μmol/100μlo fa c e t o n e )1 hb e f o r eT P A
(10nmol/100μl of acetone) treatment was applied to Group III
animals. Group IV animals were treated with topical application of
NDGA (25μmol/100μlo fa c e t o n e )1hb e f o r eT P A( 1 0n m o l / 1 0 0μl
of acetone) treatment. Groups V and VI animals received topical
applicationof15and25μmolNDGAin100μlacetone, respectively.
After 24h the same doses of NDGA or acetone were applied
1h prior to the second TPA application (10nmol/100μla c e t o n e ) .
Animals were sacriﬁced by cervical dislocation after 1h of second
TPA application. The skin application area was ∼6cm 2.
Claiborne [37] and expressed asnmol H2O2 consumed/min/
mg protein. Superoxide dismutase (SOD) activity was mea-
sured according to the method of Marklund and Marklund
[38]andexpressedasunits/mgprotein.OneunitofSODwas
deﬁned as the enzyme activity that inhibited autoxidation of
pyrogallol (Sigma) by 50%.
2.6. Histology. The formalin ﬁxed skin samples were dehy-
drated with graded ethanol (BDH), and embedded in paraf-
ﬁn (Hi-Media Labs, Mumbai, India) after rinsing with tap
water. The samples were cut by microtome at 5μma n d
mounted on glass slides. The sections were dewaxed using
xylene (BDH) solution (mixture of isomers) and graded
ethanol, and stained with hematoxylin and eosin (Hi-Media
Labs). Inﬂammatory cell (peripheral mononuclear cells)
inﬁltration and intercellular edema (accumulation of ﬂuid
between the epidermal cells) were scored as slight (+),
moderate (++) or severe (+++), while (−) indicates absence
of a signiﬁcant change. The number of nucleated cell layers
in the epidermis was determined by counting the average
numbers at ﬁve randomly selected locations per slide.
2.7. Statistical Analysis. One-way analysis of variance
(ANOVA) was applied to determine signiﬁcant diﬀerences
in results of various groups. P-values <.05 were considered
signiﬁcant. Subsequently, Tukey’s t-test was applied for ana-
lyzing the signiﬁcance between diﬀerent treatment groups.
The values are expressed as means±SE.
3.Results
3.1. Inﬂammatory Responses. Double TPA application at a
dose of 10nmol each with a 24h interval caused signiﬁcant
increase in the activity of MPO (P<.001) in TPA treated
group when compared with control group (Figure 2(a)).
Animals withNDGAtreatment showed signiﬁcant reduction
(P<.001) in MPO activity when compared to TPA-treated
group. NDGA alone at either 15 or 25μmol caused no
signiﬁcant changes in the above parameters compared to
controls. Double application of TPA 24h apart caused
signiﬁcant edema formation when compared with Group
Ia n i m a l s( P<.001) (Figure 2(b)). Animals of Groups III
and IV which were treated with 15, 25μmol of NDGA,
respectively, showed a signiﬁcantly reduced (P<.05 and .01)
edema response when compared with TPA-treated animals
(Group II).
3.2. LPO, H2O2 Production and XO Activity. TPA treated
animals showed a signiﬁcant increase (P<.001) in the levels
of LPO (Figure 3(a)), H2O2 production (Figure 3(b))a n d
XOD activity (Figure 3(c))i ns k i nw h e nc o m p a r e dw i t hc o n -
trol group. Groups III and IV (NDGA treatment) ani-
mals showed a signiﬁcant decrease in all these parameters
(P<.05–.001). NDGA alone at both the doses (15 or
25μmol) caused no signiﬁcant changes in any of the above
parameters compared to controls.
3.3. Skin Antioxidants. The double application of TPA
caused a signiﬁcant decrease in the activities of all the glu-
tathione metabolizing enzymes such as GPx (P<.001), GR
(P<.001),GST (P<.001)compared to control animals (Fig-
ures 4(b)–4(d)). Application of NDGA (15μmol) in TPA-
treated animals showed a signiﬁcant increase in the activities
of GPx (P<.05) and GR (P<. 0 5 ) .H o w e v e r ,n os i g n i ﬁ c a n t
increase in the activity of GST is observed. Similarly, higher
dose of NDGA (25μmol) showed signiﬁcant increase in
the activities of GPx (P<.01), GR (P<.01) along with a
signiﬁcant increase in GST (P<.05) activity (Figures 4(b)–
4(d)). GSH dataalso showed a signiﬁcant decrease (P<.001)4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Eﬀect of NDGA on TPA induced (a) MPO activity, (b) edema formation, (c) CAT and (d) SOD activity in mouse skin from
diﬀerent treatment groups. Values are expressed as means±SE (n=6) of units of MPO/min/mg protein, cutaneous edema as mg/punch,
catalase activity asnmol H2O2 consumed/min/mg protein and SOD activity as units/mg protein. Signiﬁcant diﬀerences are indicated by
∗∗∗P<.001whencomparedwithcontrol animals(Group I)and #P<.05, ##P<.01and ###P<.001when comparedwithTPA-treated animals
(Group II).
in TPA-treated group. NDGA along with TPA at both low
and high doses caused a signiﬁcant increase in the activities
of GSH (P<.01 and P<.001) (Figure 4(a)), Concomitant to
decrease in glutathione cycle enzymes a signiﬁcant decrease
in the activities of other antioxidant enzymes such as CAT
(P<.001) and SOD (P<.001) was also observed in the TPA-
treated animals (Group II) compared to control animals
(Figures 2(c) and 2(d)). Animals with NDGA treatment (15
and 25μmol) showed a signiﬁcant increase in the activities
of SOD and CAT when compared to TPA-treated animals.
Changes in the above parameters were not signiﬁcant when
NDGA applied alone at either 15 or 25μmol as compared to
controls.
3.4. Histological Findings. Double application of TPA caused
marked histological alteration such as increase in epidermal
cell layer, large number of inﬁltrating polymorphonuclear
leukocytes (PMNs) and intercellular edema in skin showing
inﬂammatory responses in the tissue (Figures 5(b) Table 1).
Control animals showed a normal tissue structure
(Figure 5(a)). However, Groups III and IV animals, which
were treated with NDGA (15 or 25μmol) before application
of TPA showed mitigation of the above inﬂammatory eﬀects
(Figures 5(c) and 5(d); Table 1). Animals of Groups V and
VI, which were treated with NDGA (15 and 25μmol, resp.)
showed normal skin structure with no remarkable histolog-
ical changes over the control skin (Figures 5(e) and 5(f)).Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Eﬀect of NDGA on TPA-induced (a) lipid peroxidation,
(b) H2O2 production and (c) xanthine oxidase activity in skin
of mice from diﬀerent treatment groups. Values are expressed
as means±SE (n=6) ofnmol TBARS formed/h/g tissue,nmol
H2O2/h/g tissue andμg uric acid/mg protein, respectively. Signiﬁ-
cant diﬀerences are indicated by ∗∗∗P<.001 when compared with
control animals (Group I) and #P<.05 and ###P<.001 and when
compared with TPA-treated animals (Group II).
4.Discussion
TPA is a typical tumor-promoting agent used extensively
in experimental carcinogenesis studies. Topical application
of TPA induces biochemical alterations and cellular and
histological changes leading to skin tumor promotion [21].
All these alterations in skin are deﬁned as possible mark-
ers of tumor promotion and therefore are the targets of
chemopreventive agents [21, 22]. Tumor promotion is also
accompaniedbyinﬂammation andoxidativestress. Itislikely
that a compound with strong anti-inﬂammatory and/or
antioxidant activities may be a good candidate for intercept-
ing the promotional events in tumorigenesis [39]. In this
study, we observed that NDGA was capable of modulating
many of the TPA-induced inﬂammatory and oxidative stress
responses.
Although a single TPA application is suﬃcient to induce
marker responses of tumor promotion events, the double
application of TPA has more remarkable eﬀect as it induces
two distinguishable biochemical events, namely, “priming”
and “activation” [23, 40]. The ﬁrst event is characterized
by recruitment of inﬂammatory cells such as polymor-
phonuclear leukocytes by chemotactic factors to inﬂam-
matory regions and the second event involves activation
of neutrophils or other oxidant-producing cells including
keratinocytes. The ﬁnal outcome of both the processes is
a massive inﬂammatory response, which overwhelms the
endogenousanti-inﬂammatory andantioxidantmilieuofthe
cells. Thus, it is more appropriate to test the eﬃcaciousness
of a target chemopreventive agent in double TPA application
protocol. Results of the present study indicate that double
application of TPA causes an increase in MPO activity and
skin edema formation, which are hallmarks of inﬂammatory
response. Increase in the activity ofMPO may be dueto large
number of inﬁltrating PMNs in TPA-treated group. Pretreat-
ment of NDGA inhibited these inﬂammatory biomarkers.
Accumulation of inﬂammatory cells (e.g., PMNs) as a
result of TPA application is responsible for ROS generation,
which plays an important role in skin tumor promotion
[20].
It is generally accepted that TPA acts as a strong pro-
moting agentthroughoxygen-mediatedmechanism andthat
oxygen radicals are the critical components of the tumor
promotion process [41]. Double TPA application caused
increased H2O2 production, XO activity and LPO whereas
pretreatment with NDGA markedly inhibited these eﬀects.
Murakami et al. [42] suggested that decreased levels of H2O2
might be attributable to the inhibition of O2
•− as a function
of SOD or by a nonenzymatic mechanism.
TPA application caused increase in XO activity, which
may be due to TPA-dependent induction of xanthine dehy-
drogenase (XD) synthesis and conversion of XD to XO [41].
XO activity is also correlated with the degree of hyperplasia
[43]. We also observed a close correlation between increase
in XO activity and number of epidermal cell layers in his-
tological analysis. NDGA treatment eﬀectively inhibited XO
activity and showed marked improvement in the histology of
treated skin. Dhawan et al. [44] suggested that LPO might be
one of the factors contributing to tumor formation. During6 Evidence-Based Complementary and Alternative Medicine
0
0.4
0.8
1.2
1.6
Treatment group
n
m
o
l
G
S
H
/
g
t
i
s
s
u
e
∗∗∗
##
###
I II III IV V VI
(a)
0
100
200
300
400
Treatment group
n
m
o
l
N
A
D
P
H
o
x
i
d
i
s
e
d
/
m
i
n
/
m
g
p
r
o
t
e
i
n
## #
∗∗∗
I II III IV V VI
(b)
0
40
80
120
160
200
n
m
o
l
N
A
D
P
H
o
x
i
d
i
s
e
d
/
m
i
n
/
m
g
p
r
o
t
e
i
n
##
#
∗∗∗
I II III IV V VI
Treatment group
(c)
0
40
80
120
160
200
Treatment group
#
∗∗∗
I II III IV V VI
n
m
o
l
C
D
N
B
c
o
n
j
u
g
a
t
e
s
f
o
r
m
e
d
/
m
i
n
/
m
g
p
r
o
t
e
i
n
(d)
Figure 4: Eﬀect of NDGA on TPA induced (a) GSH level, (b) GPx, (c) GR and (d) GST activity in mouse skin from diﬀerent treatment
groups. Values are expressed as means±SE (n=6) of GSH/g tissue, GPx and GR activities asnmol NADPH oxidized/min/mg protein, GST
activity asnmolCDNB conjugatesformed/min/mgprotein. Signiﬁcantdiﬀerences are indicated by ∗∗∗P<.001when comparedwithcontrol
animals (Group I) and #P<.05, ##P<.01 and ###P<.001 and when compared with TPA-treated animals (Group II).
Table 1: Anti-inﬂammatory eﬀect of topically applied NDGA on TPA-induced morphological changes in skin as measured by number of
epidermal layers, leukocyte inﬁltration and intercellular edema.
Group
Observation
No. of epidermal layers Leukocyte inﬁltration Intercellular edema
I( A c / A c ) 2 - 3 −−
II (Ac/TPA) 4–6 +++ +++
III [NDGA [15]/TPA] 3-4 + +
IV [NDGA [25]/TPA] 3-4 +/−−
V[ N D G A[ 15]/Ac] 2-3 −−
VI [NDGA [25]/Ac] 2-3 −−
Leukocytes inﬁltration and intensity of edema are indicated by slight (+), moderate (++), severe (+++), equivocal (+/−)w h i l e( −) indicates absence of any
signiﬁcant change. Ac: acetone; NDGA: nordihydroguaiaretic acid; TPA: 12-O-tetradecanoylphorbol-13-acetate.Evidence-Based Complementary and Alternative Medicine 7
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Figure 5: Eﬀect of NDGA on TPA induced morphological changes as observed byH & E, ×100. Representative pictures are shown. (a)
Photomicrograph of skin section from acetone treated control animal showing normal skin structure having well deﬁned epidermal and
dermal layers. Epidermis is just 2-3 cells thick. Superﬁcial dermis does not show any edema or PMN inﬁltration; (b) double dose of TPA
treatment showing skin with irregular epidermal thickening, severe dermal edema and inﬁltration of PMNs in upper dermis; (c) mice
treated with NDGA (15μmol) before topical application of TPA showing moderate epidermal thickening moderate dermal edema and
scattered dermalinﬁltrates;(d) sectionofskintreated withhigher doseofNDGA (25μmol)before TPA applicationshowingmildepidermal
thickening, occasional inﬁltration of leukocytes and mild edema; and (e) and (f) sections of skin from mice treated with NDGA 15 and
25μmol, respectively, followed by acetone application showing normal skin structure. Detail of histological observations is also given in
Table 1.
oxidative stress, MDA and/or other aldehydes are formed
which react with amino acids and DNA and introduce cross
linkages between proteins and nucleic acids resulting in
alteration in replication and transcription [44]. LPO is also
typically associated with tumor promotion stage. The pro-
tective eﬀect of NDGA against TPA-induced LPO reported
here along with other modulatory eﬀects on inﬂammatory
and oxidative stress responses supports chemopreventive
potential of NDGA.
Antioxidant enzymes such as CAT, SOD and GPx coun-
teract and regulate overall ROS level to maintain physi-
ological homeostasis [41]. Application of NDGA at both
doses ameliorated TPA-mediated oxidative stress including
restoration of these enzymes. Level of GSH was also restored8 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Possible pathways involving TPA induced generation
of ROS and promising targets of NDGA. (1) NDGA prevents
the TPA induced dermal inﬁltration and activation of PMNs.
(2) NDGA downregulates MPO, one of the principal enzymes
released upon PMN activation. MPO has been considered a key
constituent of the PMNs cytotoxic armament by catalyzing the
H2O2 dependent formation of HOCL, a potent oxidant. (3) It
inhibits the activity of XO and thus prevents the formation
of O2
•−.T h i sO 2
•− is a substrate for the enzyme SOD, which
catalyzes the formation of H2O2.H 2O2 may be converted into
highly reactive radical OH
•.T h i sO H
• may interact with lipid-
rich plasma membrane and DNA molecule causes LPO and DNA
damage that may result into tumor development. (4) NDGA may
quench the hydroxyl radicals and thus prevents from deleterious
eﬀects. (5) NDGA also inhibits LPO. Conﬁrmed (1–3 and 5) and
unconﬁrmed intervention (4) are shown by unbroken and bro-
kenlines,respectively. TPA, 12-O-tetradecanoylphorbol-13-acetate;
ROS, reactive oxygen species; NDGA, nordihydroguaiaretic acid;
PMNs, polymorphonuclear leukocytes; MPO, myeloperoxidase;
H2O2,hydrogen peroxide; HOCL,hypochlorous acid; XO,xanthine
oxidase; SOD, superoxide dismutse; OH
•, hydroxyl radical; LPO,
lipid peroxidation.
suggesting a multiple protective eﬀect for NDGA. GSH is
involved in maintaining intracellular redox status by reg-
ulating and controlling oxidative stress [45]. GSH directly
scavenges ROS and its loss is associated with an augmented
pro-inﬂammatory response [46].
NDGA treatment before TPA application caused im-
provement in skin histology such as changes in degree of
PMN inﬁltration, number of epidermal layer and intercellu-
lar edema. Decrease in PMN was associated with low MPO
activity and low oxidative stress in NDGA treated group.
Application of TPA caused accumulation of inﬂammatory
cells, which in turn led to excessive production of chemotac-
ticcytokines.CytokineIL-1,particularly IL-1αinmouseskin
is involved in cell proliferation and hyperplasia in the tumor
promotion stage [47]. Nakamura et al. [40] suggested that
O2
− produced by the inﬂammatory cells play an important
role in incessant and excessive production of chemotactic
factors leading to chronic inﬂammation and hyperplasia.
This study of various markers of inﬂammation and ox-
idative stress of stage I tumor promotion supported by his-
tological ﬁndings clearly indicates that NDGA has potential
chemopreventive agent acting mainly by its anti-inﬂamma-
tory and anti-oxidative properties. Although creosote bush
lignan NDGA has a long history of safe use as an alternative
medicine for topical uses in skin care system, its usage is
limited by ingestion. In addition to NDGA, several other
classes of compounds with therapeutic potential have been
found in abundance in creosote bush. The result of the
present study showed modulatory eﬀects of one of its main
active constituent NDGA against skin tumor promotion
events substantiating the use of creosote bush in alternative
therapies by the Native Americans and Mexicans.
Recently, several natural compounds having ability to
intervene oxidative stress and inﬂammation have emerged as
promising agents for cancer prevention [23–27]. For exam-
ple, curcumin has a variety of positive pharmacological ef-
fects including cancer chemoprevention. Phase I human
trials have also been performed using curcumin [48]. Salvioli
et al. [48] proposed that besides cancer, curcumin is con-
sidered as a promising drug for the treatment of other
diseases, most of which are related to aging process. Indeed
curcumin has antioxidant and anti-inﬂammatory activity.
Therefore, it could likely ameliorate other pathogenic con-
ditions that share an inﬂammatory or oxidative pathway
such as cardiovascular diseases, sporadic Alzheimer’s disease
(AD), sarcopenia, type II diabetes, arthrosis and arthritis. In
viewofpromisingresultsoncurcumin,itmaybeappropriate
to undertake clinical trials on NDGA, which has a similar
mechanism ofaction. Forthis purpose, NDGAmay be tested
as a single candidate or in combination with otherprotective
agents.
5.Conclusion
A substantial database circumstantially implicates free radi-
calsand ROSintumorpromotion[21].Skincellshavedevel-
oped a comprehensive set of antioxidant defense mechanism
to prevent free radical formation and to limit their damagingEvidence-Based Complementary and Alternative Medicine 9
eﬀects [49]. Furthermore, inﬂammatory cells (neutrophils,
macrophages, and eosinophils) are important endogenous
sources of ROS [23]. In this study, we observed that double
application of TPA is responsible for increase in oxidative
stress and inﬂammation. As shown in Figure 6, application
of TPA causes the inﬁltration of PMN at the site of exposure.
TPA stimulates PMNs to undergo an oxidative burst that
is characterized by rapid formation of O2
•− and H2O2.
These inﬁltrated leukocytes have been shown to be major
sources of reactive oxygen species generation. Also, PMNs
activate oxidant-generating myeloperoxidase. MPO is the
most abundant protein found in azeurophilic granule of
PMN. Stimulation of PMN leads to degranulations, whereby
thecontentsofthegranules are released intothe extracellular
milieu causing cellular and tissue damage. Excessive produc-
tion of reactive oxygen species due to massive activation of
PMN resulting from TPA application can injure cellular bio-
molecules such as nucleic acids, proteins, carbohydrates and
lipids, which may leads to tumor development. As indicated
in Figure 6 (target 1–5), NDGA aﬀorded protection by
intercepting at various stages of inﬂammation and oxidative
stress, which makes it a potential candidate for skin cancer
chemoprevention.
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